Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2002-05-16

Original market date: See footnote 1

1979-12-31

Product name:

POLLINEX R

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

00464988

Product Monograph/Veterinary Labelling:

Date: 2017-09-29 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

ALLERGY THERAPEUTICS (UK) LTD
Dominion Way
Worthing
West Sussex
United Kingdom  BN14 8SA

Class: 

Human

Dosage form(s):

Liquid

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

4

Schedule(s):

Schedule D  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

92:05.00* See footnote 6   ALLERGENIC EXTRACTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

V01AA02  GRASS POLLEN

Active ingredient group (AIG) number:See footnote 5

0447001001

List of active ingredient(s)
Active ingredient(s) Strength
MODIFIED RAGWEED TYROSINE ADSORBATE 1400 UNIT / ML
MODIFIED RAGWEED TYROSINE ADSORBATE 210 UNIT / ML
MODIFIED RAGWEED TYROSINE ADSORBATE 4300 UNIT / ML
MODIFIED RAGWEED TYROSINE ADSORBATE 500 UNIT / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: